Cargando…
Ivermectin for Coronavirus Disease 2019: Yet to Be Well Evaluated Before Clinical Use
Autores principales: | Hagiya, Hideharu, Otsuka, Fumio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272976/ https://www.ncbi.nlm.nih.gov/pubmed/34362568 http://dx.doi.org/10.1016/j.clinthera.2021.07.007 |
Ejemplares similares
-
Therapeutic Drug Monitoring for Aminoglycosides: Not Yet Readily Available in Japanese University Hospitals
por: Hagiya, Hideharu, et al.
Publicado: (2021) -
High-Dose Corticosteroids for a Pregnant Woman Critically Ill With Coronavirus Disease 2019
por: Yamamoto, Koichiro, et al.
Publicado: (2021) -
Remarks About Retrospective Analysis of Ivermectin Effectiveness on Coronavirus Disease 2019 (ICON Study)
por: Ortega-Guillén, Eduardo, et al.
Publicado: (2021) -
Letter to the Editor: A Need for Infectious Disease Specialists in Public Healthcare Centers?
por: Hagiya, Hideharu
Publicado: (2023) -
No Association Observed Between the Number of Infectious Disease Experts and Prevalence of Antimicrobial-Resistant Pathogens in Japan
por: Hagiya, Hideharu, et al.
Publicado: (2021)